Australian researchers might have found a way to halt the progression of mesothelioma, a lung cancer caused by asbestos exposure. Although regulations exist to protect workers, asbestos is a danger in many occupations.
The researchers have developed a compound that can potentially be utilized in a puffer-administered medication, much like an asthma inhaler. According to the researchers, the compound was able to stop the development of mesothelioma in 60 to 80 percent of asbestos-exposed mice during the duration of a 30-week trial.
The mesothelioma-fighting compound is capable of stopping cell death caused by asbestos fibers. This mechanism of action allows the immune system to mount a defense against asbestos fibers lodged in lung tissue.
Who Is At Risk For Developing Mesothelioma?
Caused by asbestos exposure, mesothelioma is an incurable form of cancer that attacks the lining of the lungs. According to the National Cancer Institute, asbestos was widely used in North America since the late 1800s. However, in the late 1970s, asbestos faced nationwide bans after it was discovered to be a potent carcinogen.
Mesothelioma symptoms can appear up to 30 years after exposure to asbestos. Employers are required by Occupational Safety and Health Administration regulations to reduce worker exposure to asbestos. Workers that develop mesothelioma or other asbestos-related lung diseases might be able to receive workers’ comp, disability and additional benefits to help pay for lost income and the cost of treatment.
For more information on occupational diseases
such as asbestosis and mesothelioma, please explore our website.
Larrimer & Larrimer, LLC
– Columbus Workers’ Comp Attorneys